Annual SG&A
$137.81 M
+$621.00 K+0.45%
31 December 2021
Summary:
Aerie Pharmaceuticals annual selling, general & administrative expenses is currently $137.81 million, with the most recent change of +$621.00 thousand (+0.45%) on 31 December 2021. During the last 3 years, it has risen by +$621.00 thousand (+0.45%).AERI Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$33.88 M
+$5.73 M+20.35%
30 September 2022
Summary:
Aerie Pharmaceuticals quarterly selling, general & administrative expenses is currently $33.88 million, with the most recent change of +$5.73 million (+20.35%) on 30 September 2022.AERI Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$4.64 B
+$11.41 M+0.24%
30 September 2022
Summary:
Aerie Pharmaceuticals TTM selling, general & administrative expenses is currently -$4.64 billion, with the most recent change of +$11.41 million (+0.24%) on 30 September 2022.AERI TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AERI Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | +0.5% | -2.2% | -3495.2% |
| 5 y5 years | +14.3% | +5.3% | -3545.3% |
AERI Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time | -0.4% | -8.2% | -3441.2% |
Aerie Pharmaceuticals Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2022 | - | $33.88 M(+20.4%) | $129.56 M(-0.6%) |
| June 2022 | - | $28.15 M(-10.7%) | $130.34 M(-4.7%) |
| Mar 2022 | - | $31.52 M(-12.5%) | $136.73 M(-0.8%) |
| Dec 2021 | $137.81 M(+0.5%) | $36.01 M(+3.9%) | $137.81 M(+0.7%) |
| Sept 2021 | - | $34.66 M(+0.3%) | $136.81 M(+2.0%) |
| June 2021 | - | $34.54 M(+6.0%) | $134.19 M(+1.0%) |
| Mar 2021 | - | $32.60 M(-6.9%) | $132.88 M(-3.1%) |
| Dec 2020 | $137.18 M(-0.9%) | $35.02 M(+9.3%) | $137.18 M(-0.3%) |
| Sept 2020 | - | $32.03 M(-3.6%) | $137.63 M(-0.1%) |
| June 2020 | - | $33.24 M(-9.9%) | $137.78 M(-0.9%) |
| Mar 2020 | - | $36.90 M(+4.0%) | $139.02 M(+0.4%) |
| Dec 2019 | $138.40 M(+14.7%) | $35.47 M(+10.2%) | $138.40 M(+2.7%) |
| Sept 2019 | - | $32.17 M(-6.7%) | $134.82 M(-0.4%) |
| June 2019 | - | $34.48 M(-5.0%) | $135.34 M(+1.0%) |
| Mar 2019 | - | $36.28 M(+13.8%) | $133.97 M(+11.1%) |
| Dec 2018 | $120.61 M(+112.0%) | $31.89 M(-2.4%) | $120.61 M(+28.0%) |
| Sept 2018 | - | $32.69 M(-1.3%) | $94.23 M(+15.9%) |
| June 2018 | - | $33.11 M(+44.4%) | $81.32 M(+24.4%) |
| Mar 2018 | - | $22.93 M(+316.7%) | $65.36 M(+14.9%) |
| Dec 2017 | $56.91 M | $5.50 M(-72.2%) | $56.91 M(+1.1%) |
| Sept 2017 | - | $19.77 M(+15.3%) | $56.29 M(+19.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2017 | - | $17.15 M(+18.5%) | $47.15 M(+19.7%) |
| Mar 2017 | - | $14.47 M(+195.9%) | $39.38 M(+13.5%) |
| Dec 2016 | $34.71 M(+13.3%) | $4.89 M(-54.0%) | $34.71 M(-7.4%) |
| Sept 2016 | - | $10.63 M(+13.2%) | $37.46 M(+9.2%) |
| June 2016 | - | $9.39 M(-4.2%) | $34.30 M(+5.8%) |
| Mar 2016 | - | $9.80 M(+28.2%) | $32.41 M(+5.8%) |
| Dec 2015 | $30.64 M(+52.4%) | $7.65 M(+2.5%) | $30.64 M(+4.3%) |
| Sept 2015 | - | $7.46 M(-0.5%) | $29.37 M(+9.4%) |
| June 2015 | - | $7.50 M(-6.5%) | $26.85 M(+9.5%) |
| Mar 2015 | - | $8.02 M(+25.8%) | $24.51 M(+21.9%) |
| Dec 2014 | $20.10 M(+95.4%) | $6.38 M(+29.0%) | $20.10 M(+16.1%) |
| Sept 2014 | - | $4.94 M(-4.3%) | $17.32 M(+10.6%) |
| June 2014 | - | $5.17 M(+43.1%) | $15.66 M(+26.0%) |
| Mar 2014 | - | $3.61 M(+0.5%) | $12.43 M(+20.9%) |
| Dec 2013 | $10.29 M(+104.9%) | $3.59 M(+9.3%) | $10.29 M(+28.4%) |
| Sept 2013 | - | $3.29 M(+69.4%) | $8.01 M(+30.5%) |
| June 2013 | - | $1.94 M(+32.3%) | $6.14 M(+46.2%) |
| Mar 2013 | - | $1.47 M(+11.1%) | $4.20 M(+53.6%) |
| Dec 2012 | $5.02 M(+42.6%) | $1.32 M(-6.9%) | $2.73 M(+93.1%) |
| Sept 2012 | - | $1.42 M | $1.42 M |
| Dec 2011 | $3.52 M | - | - |
FAQ
- What is Aerie Pharmaceuticals annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Aerie Pharmaceuticals?
- What is Aerie Pharmaceuticals quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Aerie Pharmaceuticals?
- What is Aerie Pharmaceuticals TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Aerie Pharmaceuticals?
What is Aerie Pharmaceuticals annual selling, general & administrative expenses?
The current annual SG&A of AERI is $137.81 M
What is the all time high annual SG&A for Aerie Pharmaceuticals?
Aerie Pharmaceuticals all-time high annual selling, general & administrative expenses is $138.40 M
What is Aerie Pharmaceuticals quarterly selling, general & administrative expenses?
The current quarterly SG&A of AERI is $33.88 M
What is the all time high quarterly SG&A for Aerie Pharmaceuticals?
Aerie Pharmaceuticals all-time high quarterly selling, general & administrative expenses is $36.90 M
What is Aerie Pharmaceuticals TTM selling, general & administrative expenses?
The current TTM SG&A of AERI is -$4.64 B
What is the all time high TTM SG&A for Aerie Pharmaceuticals?
Aerie Pharmaceuticals all-time high TTM selling, general & administrative expenses is $139.02 M